Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

Weight loss drugs Ozempic and Wegovy would no longer be covered by California’s health insurance for low-income people under ...

Costly drugs: The drugs prescribed to fight obesity have been driving up the cost of Medi-Cal, the state program that ...

Aide to RFK Jr. says White House is pushing for global price parity on GLP-1 drugs for weight loss. Read more here.

Popular drugs for weight loss are now being prescribed to kids as young as 12. It’s been nearly two years since the FDA approved their use in kids, but some are questioning if these drugs are safe for ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...